RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Oramed Pharmaceuticals Stock

Oramed Pharmaceuticals Employees 2025

Oramed Pharmaceuticals Employees

12

Ticker

ORMP

ISIN

US68403P2039

WKN

A1CTNU

In 2025, Oramed Pharmaceuticals employed 12 people, a 0% change from the 12 number of employees in the previous year.

Oramed Pharmaceuticals Aktienanalyse

What does Oramed Pharmaceuticals do?

Oramed Pharmaceuticals Inc is an innovative biotech company headquartered in Jerusalem, Israel. The company was founded in 2006 by Nadav Kidron and specializes in the development of oral forms of protein-based therapeutics. The idea behind Oramed Pharmaceuticals was to revolutionize the way proteins are administered. Typically, protein-based drugs like insulin need to be administered in injectable form, which can be unpleasant and painful for many patients. Oramed Pharmaceuticals set out to find a solution to this problem. The company has developed a technology called ORMD-0801, which allows for the oral administration of insulin. The active ingredient is protected by a special capsule that monitors the pH level in the stomach. Once the capsule reaches the small intestine, the active ingredient is released and can be absorbed by the body. Oramed Pharmaceuticals aims to improve the treatment of diabetes. With the oral form of insulin, patients can take their medication much easier and more conveniently. This can help improve treatment and increase patients' quality of life. In addition to the development of ORMD-0801, Oramed Pharmaceuticals is also working on developing oral forms of other protein-based therapeutics. The company has filed a variety of patents for technologies and therapies and actively collaborates with other companies and research institutions. Oramed Pharmaceuticals has two main divisions: the development department and the commercialization department. The development department is responsible for the research and development of new therapies, while the commercialization department is responsible for sales and marketing of the products. Oramed Pharmaceuticals' business model is focused on developing innovative therapies and bringing them to market. The company works closely with other companies and research institutions to advance the development of new therapies. Oramed Pharmaceuticals is currently working on several projects to develop additional orally administered protein-based therapeutics. In addition to insulin, the company is also working on proteins that can be used in the treatment of other diseases such as osteoporosis and Parkinson's. The products of Oramed Pharmaceuticals are of great importance to both patients and the medical community. The oral forms of protein-based therapeutics can help make the treatment of diabetes and other diseases much easier and more convenient. This can help increase patient satisfaction and improve compliance. In recent years, Oramed Pharmaceuticals has received several awards and accolades for its innovative products. The company continues to work on developing new therapies and changing the way medication is administered. Oramed Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Oramed Pharmaceuticals's Employee Base

Oramed Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Oramed Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Oramed Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Oramed Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Oramed Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Oramed Pharmaceuticals stock

How many employees does Oramed Pharmaceuticals have this year?

Oramed Pharmaceuticals has 12 undefined employees this year.

How many employees did Oramed Pharmaceuticals have compared to the previous year?

Compared to the previous year, Oramed Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Oramed Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Oramed Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Oramed Pharmaceuticals?

The number of employees can also have an impact on investors of Oramed Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Oramed Pharmaceuticals affect the company?

An increase in equity of Oramed Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Oramed Pharmaceuticals's equity affect the company?

A reduction in equity of Oramed Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Oramed Pharmaceuticals?

Some factors that can influence the equity of Oramed Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Oramed Pharmaceuticals so important for investors?

The equity of Oramed Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Oramed Pharmaceuticals influence the company?

The number of employees at Oramed Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Oramed Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Oramed Pharmaceuticals has changed by 0.

How many employees does Oramed Pharmaceuticals currently have?

Oramed Pharmaceuticals currently has 12 undefined employees.

Why is the number of employees important for investors of Oramed Pharmaceuticals?

The number of employees is important for investors of Oramed Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Oramed Pharmaceuticals take to change the number of employees?

To change the number of employees, Oramed Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Oramed Pharmaceuticals pay?

Over the past 12 months, Oramed Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oramed Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Oramed Pharmaceuticals?

The current dividend yield of Oramed Pharmaceuticals is .

When does Oramed Pharmaceuticals pay dividends?

Oramed Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oramed Pharmaceuticals?

Oramed Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Oramed Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oramed Pharmaceuticals located?

Oramed Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oramed Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oramed Pharmaceuticals from 8/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/8/2025.

When did Oramed Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/8/2025.

What was the dividend of Oramed Pharmaceuticals in the year 2024?

In the year 2024, Oramed Pharmaceuticals distributed 0 USD as dividends.

In which currency does Oramed Pharmaceuticals pay out the dividend?

The dividends of Oramed Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Oramed Pharmaceuticals

Our stock analysis for Oramed Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oramed Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.